DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,184 | -0.9% | 956 | -4.0% | 0.01% | 0.0% |
| Q2 2023 | $239,309 | -15.6% | 996 | -11.4% | 0.01% | -18.2% |
| Q1 2023 | $283,600 | -29.8% | 1,124 | -26.1% | 0.01% | -35.3% |
| Q4 2022 | $404,084 | +164.1% | 1,521 | +156.5% | 0.02% | +142.9% |
| Q3 2022 | $153,000 | -14.0% | 593 | -15.5% | 0.01% | -12.5% |
| Q2 2022 | $178,000 | +270.8% | 702 | +325.5% | 0.01% | +300.0% |
| Q1 2022 | $48,000 | -11.1% | 165 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $54,000 | +8.0% | 165 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $50,000 | +13.6% | 165 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $44,000 | +18.9% | 165 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $37,000 | -2.6% | 165 | -2.4% | 0.00% | -33.3% |
| Q4 2020 | $38,000 | +8.6% | 169 | +3.7% | 0.00% | 0.0% |
| Q3 2020 | $35,000 | +75.0% | 163 | +44.2% | 0.00% | +50.0% |
| Q2 2020 | $20,000 | +25.0% | 113 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | -5.9% | 113 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $17,000 | +30.8% | 113 | +28.4% | 0.00% | 0.0% |
| Q3 2019 | $13,000 | 0.0% | 88 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $13,000 | +30.0% | 88 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,000 | 0.0% | 88 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $10,000 | +11.1% | 88 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $9,000 | +12.5% | 88 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | -90.6% | 88 | -90.4% | 0.00% | -88.9% |
| Q4 2017 | $85,000 | +7.6% | 918 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $79,000 | -1.2% | 918 | -3.1% | 0.01% | 0.0% |
| Q2 2017 | $80,000 | +12.7% | 947 | +14.1% | 0.01% | +12.5% |
| Q1 2017 | $71,000 | +9.2% | 830 | 0.0% | 0.01% | +14.3% |
| Q4 2016 | $65,000 | – | 830 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |